Cynthia Lynn Anderson Vista Gen Therapeutics, Inc. (VTGN) insider trading activity

VTGN Quotes by TradingView

Cynthia Lynn Anderson is CHIEF FINANCIAL OFFICER of VistaGen Therapeutics, Inc.. Currently has a direct ownership of 12,801 shares of VTGN, which is worth approximately $32,514. The most recent transaction as insider was on Jun 30, 2025, when has been sold 6,617 shares (Common Stock) at a price of $1.7 per share, resulting in proceeds of $11,248. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.8K
107.0% 3M change
256.38% 12M change
Total Value Held $32,514

Cynthia Lynn Anderson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2025
BUY
Grant, award, or other acquisition
$11,248 $1.7 p/Share
6,617 Added 34.08%
12,801 Common Stock
Dec 31 2024
BUY
Grant, award, or other acquisition
$6,505 $2.51 p/Share
2,592 Added 29.54%
6,184 Common Stock
Jun 28 2024
BUY
Grant, award, or other acquisition
$10,632 $2.96 p/Share
3,592 Added 50.0%
3,592 Common Stock
CLA

Cynthia Lynn Anderson

CHIEF FINANCIAL OFFICER
South San Francisco, CA

Track Institutional and Insider Activities on VTGN

Follow VistaGen Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VTGN shares.

Notify only if

Insider Trading

Get notified when an Vista Gen Therapeutics, Inc. insider buys or sells VTGN shares.

Notify only if

News

Receive news related to VistaGen Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VTGN